Millennium Management’s Sage Therapeutics SAGE Stock Holding History

Millennium Management’s Portfolio SAGE Stock Details SAGE Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q1	–	Sell	-50,000	Closed	-$3.61M	–	4387
2019 Q4	$3.61M	Buy	+50,000	New	+$6.15M	﹤0.01%	2184
2019 Q1	–	Sell	-50,200	Closed	-$4.81M	–	4283
2018 Q4	$4.81M	Buy	+50,200	New	+$5.75M	0.01%	1617
2018 Q1	–	Sell	-25,000	Closed	-$4.12M	–	4023
2017 Q4	$4.12M	Hold	25,000	–	–	0.01%	1841
2017 Q3	$1.56M	Buy	+25,000	New	+$1.96M	﹤0.01%	2288
2017 Q1	–	Sell	-27,100	Closed	-$1.38M	–	3800
2016 Q4	$1.38M	Buy	+27,100	New	+$1.28M	﹤0.01%	2072

Other funds holding SAGE

DekaBank Deutsche Girozentrale Frankfurt, Germany $60.6B AUM 23.27% 1-Year Est. Return

Osaic Holdings Scottsdale, Arizona $68.3B AUM 20.5% 1-Year Est. Return

IFP Advisors Tampa, Florida $4.82B AUM 20.19% 1-Year Est. Return

HNB

Huntington National Bank Columbus, Ohio $18.1B AUM 24.69% 1-Year Est. Return

Millennium Management's SAGE Position: Q3 2025 in Review

Millennium Management sold out of Sage Therapeutics (SAGE) in Q3 2025, closing a stake of 1,002,709 shares — an estimated $9.14M sold.

Millennium Management first reported a position in SAGE in Q3 2014 and held it in 38 quarters. The position peaked at $59.5M in Q2 2018. 5 funds tracked by Wall St. Rank hold SAGE as of Q3 2025.

Millennium Management reported no remaining Sage Therapeutics position as of Q3 2025 after selling out during the quarter.
Millennium Management sold 1,002,709 Sage Therapeutics shares in Q3 2025, an estimated $9.14M.
Millennium Management first reported a position in Sage Therapeutics in Q3 2014 and held it in 38 quarters.
Millennium Management's Sage Therapeutics position peaked at $59.5M in Q2 2018.
5 funds tracked by Wall St. Rank held Sage Therapeutics as of Q3 2025.

Based on Millennium Management's 13F filing for Q3 2025, filed 14 Nov 2025.